Pitcairn CO Repligen Corp Transaction History

Pitcairn CO

$1.63 Billion
Q1 2025

A detailed history of Pitcairn CO transactions in Repligen Corp stock. As of the latest transaction made, Pitcairn CO holds 4,278 shares of RGEN stock, worth $524,226. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,278

Previous 4,454 3.95%

Holding current value

$524,226

Previous $641,000 15.13%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$127.24 - $174.24 $22,394 - $30,666	-176 Reduced 3.95%	4,278 $544,000
Q4 2024 Feb 12, 2025	SELL	$123.41 - $160.92 $16,043 - $20,919	-130 Reduced 2.84%	4,454 $641,000
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $38,093 - $53,217	-318 Reduced 6.49%	4,584 $682,000
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $90,720 - $138,310	756 Added 18.23%	4,902 $617,000
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $9,392 - $11,463	-55 Reduced 1.31%	4,146 $762,000
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $8,106 - $13,159	-71 Reduced 1.66%	4,201 $755,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $3,469 - $4,412	-25 Reduced 0.58%	4,272 $679,000
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $3,045 - $3,966	22 Added 0.51%	4,297 $607,000
Q1 2023 May 05, 2023	BUY	$154.26 - $198.1 $1,851 - $2,377	12 Added 0.28%	4,275 $719,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $47,101 - $63,962	-290 Reduced 6.37%	4,263 $721,000
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $4,010 - $6,405	25 Added 0.55%	4,553 $852,000
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $6,049 - $8,084	43 Added 0.96%	4,528 $735,000
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $9,993 - $15,993	62 Added 1.4%	4,485 $844,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $12,379 - $15,223	-50 Reduced 1.12%	4,423 $1.17 Million
Q3 2021 Nov 10, 2021	SELL	$194.77 - $324.21 $32,331 - $53,818	-166 Reduced 3.58%	4,473 $1.29 Million
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $13,933 - $18,559	-84 Reduced 1.78%	4,639 $926,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $14,970 - $18,779	83 Added 1.79%	4,723 $919,000
Q4 2020 Feb 05, 2021	BUY	$148.08 - $206.57 $1,332 - $1,859	9 Added 0.19%	4,640 $889,000
Q3 2020 Nov 03, 2020	SELL	$122.51 - $158.27 $7,350 - $9,496	-60 Reduced 1.28%	4,631 $684,000
Q2 2020 Jul 28, 2020	SELL	$94.33 - $140.48 $44,335 - $66,025	-470 Reduced 9.11%	4,691 $580,000
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $41,545 - $53,369	489 Added 10.47%	5,161 $498,000
Q4 2019 Feb 12, 2020	BUY	$73.84 - $93.08 $55,380 - $69,810	750 Added 19.12%	4,672 $433,000
Q3 2019 Nov 12, 2019	BUY	$76.65 - $95.51 $11,727 - $14,613	153 Added 4.06%	3,922 $301,000
Q2 2019 Aug 12, 2019	BUY	$54.2 - $85.95 $13,279 - $21,057	245 Added 6.95%	3,769 $324,000
Q1 2019 May 07, 2019	BUY	$49.45 - $62.8 $174,261 - $221,307	3,524 New	3,524 $209,000

Others Institutions Holding RGEN

# of Institutions

494

Shares Held

57.6M

Call Options Held

75.6K

Put Options Held

521K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.8B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account